Nontuberculosis mycobacterial infections at a specialized tuberculosis treatment centre in the Republic of Korea

[1] Kendall BA(2013)Update on the epidemiology of pulmonary nontuberculous mycobacterial infections Semin Respir Crit Care Med 34 87-94

[2] Winthrop KL(2013)The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study Eur Respir J 42 1604-1613

[3] Hoefsloot W(2015)Nontuberculous mycobacteria in Middle East: current situation and future challenges Int J Mycobacteriol 4 7-17

[4] Velayati AA(2015)Nontuberculous mycobacteria pathogenesis and biofilm assembly Int J Mycobacteriol. 4 36-43

[5] Sousa S(2010)Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger PLoS Negl Trop Dis 4 1007-1014

[6] Gopinath K(2014)A guide for the utilization of Health Insurance Review and Assessment Service national patient samples Epidemiol Health 36 2143-2150

[7] Singh S(1987)The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a National Survey 1 Am Rev Respir Dis 135 343-345

[8] Kim L(2016)Increasing prevalence rate of nontuberculous mycobacteria infections in five states, 2008-2013 Ann Am Thorac Soc 13 367-416

[9] Kim JA(2010)Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist’s view Future Microbiol 5 185-190

[10] Kim S(2007)An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 1370-1377

[1] Kendall BA(2013)Update on the epidemiology of pulmonary nontuberculous mycobacterial infections Semin Respir Crit Care Med 34 87-94

[2] Winthrop KL(2013)The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study Eur Respir J 42 1604-1613

[3] Hoefsloot W(2015)Nontuberculous mycobacteria in Middle East: current situation and future challenges Int J Mycobacteriol 4 7-17

[4] Velayati AA(2015)Nontuberculous mycobacteria pathogenesis and biofilm assembly Int J Mycobacteriol. 4 36-43

[5] Sousa S(2010)Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger PLoS Negl Trop Dis 4 1007-1014

[6] Gopinath K(2014)A guide for the utilization of Health Insurance Review and Assessment Service national patient samples Epidemiol Health 36 2143-2150

[7] Singh S(1987)The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a National Survey 1 Am Rev Respir Dis 135 343-345

[8] Kim L(2016)Increasing prevalence rate of nontuberculous mycobacteria infections in five states, 2008-2013 Ann Am Thorac Soc 13 367-416

[9] Kim JA(2010)Pulmonary disease due to nontuberculous mycobacteria: an epidemiologist’s view Future Microbiol 5 185-190

[10] Kim S(2007)An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases Am J Respir Crit Care Med 175 1370-1377